1E Therapeutics raised $120M seed funding to develop RNA-targeting therapies
Biospace - 09-Dec-2021Biotech experts back 1E, believing it can transform medical treatments
Alvin Clavines
Freelance writer
Alvin Clavines writes for BioSpace, contributing articles focused on biotechnology and life sciences. His work covers industry insights and trends.
Visit website: https://www.biospace.com/alvin-clavines
See also
Details last updated 13-Nov-2024
Articles written by Alvin Clavines
